ApprovalTrail

Drug · DIN 02463156

TRIPLE ESSENTIALS

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since May 19, 2020; first marketed June 27, 2017.
Drug Identification Number (DIN)
02463156
Company (DIN owner)
Blistex CorporationMississauga, Ontario, Canada
Schedule
Non-prescription drugs
Dosage form
Stick
Route
Topical
Therapeutic class (ATC)
Combinations of protectives against uv-radiation D02BA30
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
OCTINOXATE6.6 %W/W
OCTISALATE4.4 %W/W